The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries (LMICs). We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic, with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work with our partners to prevent and treat infectious diseases such as COVID-19, Ebola, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are also investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication, and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skill sets and life experiences. CHAI is deeply grounded in the countries we work in, with the majority of our staff based in program countries. Learn more about our exciting work: www.clintonhealthaccess.org
CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion, and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.
CHAI’s Market Shaping Team Overview
The CHAI Market Shaping Team (MST) is responsible for envisioning, executing, and monitoring market shaping interventions aimed at improving access to health commodities for LMICs. MST shapes markets across the full product continuum, from R&D and regulatory strategy through manufacturing, procurement, and country introduction, adoption and scale-up. Interventions include target product profile development, pooled procurement, demand forecasting, negotiation of access terms, and supply chain optimization. Where a specific barrier requires it, CHAI structures risk-sharing instruments — advance market commitments, volume guarantees, product subsidies, procurement and payment guarantees, and working capital facilities — matched to that barrier and stage of the product lifecycle. Equally, MST works on the demand-side to convert improved access terms into uptake, partnering with governments and country teams to build the evidence and policy case for adoption, secure guideline inclusion and financing, plan product introduction and scale-up, and strengthen the workforce, supply chain, and service delivery capacity needed to reach patients. This work also generates the demand signals and volume forecasts that underpin MST's supply-side negotiations.
MST collaborates closely with internal and external stakeholders to maximize the public health impact of a proposed intervention and ensure alignment with current and future policy goals. MST also works to build stronger relationships with manufacturers and distributors to devise and execute sustainable solutions for improved access to health commodities. Examples of the types of market shaping efforts CHAI has been involved with include the following:
Position Overview
CHAI’s Market Shaping Team is seeking a Manager or Senior Manager to advance CHAI's market shaping activities for a portfolio of artificial intelligence (AI)-supported diagnostics, including AI-enabled point-of-care ultrasound (AI-POCUS) and other tools, to transform diagnostic capability in LMICs.
The Manager, AI Diagnotics will collaborate with CHAI’s global program teams, global cross-cutting functional teams, and country teams as well as external stakeholders to design and execute CHAI’s global supply- and demand-side market shaping strategies for AI diagnostics in LMICs. In doing so, the Manager will build and maintain strong relationships with internal and external stakeholders, including global and country teams, governments, donors, normative bodies, implementing partners, research partners, AI and diagnostic companies, and key opinion leaders to coordinate strategy, planning, and execution of interventions.
The Manager should be a highly motivated, entrepreneurial individual with outstanding problem-solving abilities and communication skills who share in CHAI’s mission and values. The individual must be able to function independently, manage a few direct reports, balance multiple priorities simultaneously, have a strong commitment to excellence, and work effectively across a range of stakeholders in a multicultural environment. CHAI also places great value on the following personal qualities: humility, resourcefulness, and tenacity.
This position will sit within CHAI's Market Shaping Team; the specific reporting line will be confirmed at offer stage. This role can be offered at either the Manager or Senior Manager level, commensurate with the qualifications and experience of the candidate. It can be based in the United States or in a CHAI program country, subject to MST and country team leadership approval and ability to obtain work authorization. A minimum 25% of travel is expected for partner, country, and supplier meetings.
Advantages
#jobreference3 #region1 #region2 #region3 #region4
Software Powered by ICIMS
www.icims.com